Oaktree Capital
SuperinvestorOaktree Capital Management LP
- SEC CIK
- 0000949509
- Manager
- Howard Marks
- Style
- Value
- Latest filing
- Aug 13, 2026
INDV holding history
Indivior Pharmaceuticals, Inc. in every 13F filed by Oaktree Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INDV overviewAll 13F holders of INDVFull Q2 2026 holdings
- Shares (Q2 2026)
- 6,127,212
- Value
- $251.4M
- % of portfolio
- 4.7%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,127,212 | $251.4M | 4.7% | −856,890−12.3% | Reduced | Holders |
| Q1 2026 | 6,984,102 | $212.9M | 3.6% | −124,542−1.8% | Reduced | Holders |
| Q4 2025 | 7,108,644 | $255.1M | 4.1% | −250,676,754−97.2% | Reduced | Holders |
| Q3 2025 | 257,785,398 | $10.7M | 0.2% | +246,776,273+2,241.6% | Added | Holders |
| Q2 2025 | 11,009,125 | $162.3M | 3.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 11,009,125 | $103.5M | 2.1% | +2,275,577+26.1% | Added | Holders |
| Q4 2024 | 8,733,548 | $112.0M | 2.1% | −788,432−8.3% | Reduced | Holders |
| Q3 2024 | 9,521,980 | $94.1M | 1.6% | +5,028,807+111.9% | Added | Holders |
| Q2 2024 | 4,493,173 | $70.4M | 1.2% | +1,141,937+34.1% | Added | Holders |
| Q1 2024 | 3,351,236 | $71.7M | 1.1% | +3,351,236 | New | Holders |